Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma

(2011) Sigbjørn Smeland et al.   Acta Orthopaedica

Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

(2011) Jakob K. Anninga et al.   EUROPEAN JOURNAL OF CANCER

The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

(2010) D. Andreou et al.   ANNALS OF ONCOLOGY

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) P. C. W. Hogendoorn et al.   ANNALS OF ONCOLOGY

The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002

(2010) Rachel Eyre et al.   BMC CANCER

Review of Adherence-Related Issues in Adolescents and Young Adults With Cancer

(2010) Phyllis Butow et al.   JOURNAL OF CLINICAL ONCOLOGY

Osteosarcoma incidence and survival rates from 1973 to 2004

(2009) Lisa Mirabello et al.   CANCER

Prognostic factors in localized extremity osteosarcoma: A systematic review

(2009) J.A.M. Bramer et al.   EJSO

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

(2008) Paul A. Meyers et al.   JOURNAL OF CLINICAL ONCOLOGY